Golimumab for rheumatoid arthritis-Reference-Cited by-同舟云学术

Golimumab for rheumatoid arthritis

Published:2010-01-20 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Singh Jasvinder A¹,Noorbaloochi Shahrzad²,Singh Gurkirpal³

Affiliation:

1. Minneapolis VA Medical Center; Medicine; 1 Veterans Drive Rheumatology (111R) Minneapolis Minnesota USA 55417

2. Minneapolis VA Medical Center and University of Minnesota; Medicine; One Veterans Drive Minneapolis MN USA 55417

3. Stanford University School of Medicine; Division of Gastroenterology and Hepatology; 703 Welch Road, Suite F-5, Palo Alto, CA 94304 Palo Alto CA USA 94304

Publisher

Wiley

Subject

Pharmacology (medical)

Reference50 articles.

1. Golimumab, a human anti-tumor necrosis factor alpha monoclonal antibody, injected subcutaneously every four weeks in methotrexate-naive patients with active rheumatoid arthritis: Twenty-four-week results of a phase III, multicenter, randomized, double-blind, placebo-controlled study of golimumab before methotrexate as first-line therapy for early-onset rheumatoid arthritis;Emery;Arthritis Rheum,2009

2. Golimumab in patients with active rheumatoid arthritis despite treatment with methotrexate: a randomized, double-blind, placebo-controlled, dose-ranging study;Kay;Arthritis Rheum,2008

3. Golimumab, a human antibody to tumour necrosis factor {alpha} given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study;Keystone;Ann Rheum Dis,2009

4. Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial;Smolen;Lancet,2009

5. New data shows golimumab significantly improves signs and symptoms of rheumatoid arthritis;O'Connell;Geriatric Medicine,2008

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exosomes and exosomal miRNAs: A new avenue for the future treatment of rheumatoid arthritis;Heliyon;2024-03

2. Research progress of targeted therapy regulating Th17/Treg balance in bone immune diseases;Frontiers in Immunology;2024-01-30

3. Therapeutic advances in rheumatoid arthritis;BMJ;2024-01-17

4. Rheumatoid arthritis: Pathophysiology, current therapeutic strategies and recent advances in targeted drug delivery system;Materials Today Communications;2023-06

5. Signaling pathways in rheumatoid arthritis: implications for targeted therapy;Signal Transduction and Targeted Therapy;2023-02-17